Risk factors of self-medication in pregnant women: a study of non-steroidal Anti-inflammatory drugs
DOI:
https://doi.org/10.33448/rsd-v10i15.22993Keywords:
Self-medication; Non-steroidal anti-inflammatory drugs; Fetuses and pregnant women.Abstract
Objective: To analyze the potential risks to pregnant women and fetuses caused by self-medication of non-steroidal anti-inflammatory drugs. Methods: The proposed methodology for this research follows a strategy of literature review, exploratory and descriptive research, whose collection was carried out in different databases, such as Scientific Electronic Library Online (SCIELO), records from both the Virtual Health Library (BVS), and records of the Medical Literature Analysis and Retrievel System Online (MEDLINE/PUBMED). The search took place through the use of the descriptors “SELF MEDICATION”; “PREGNANT”, “AINES” and “RISKS”. Results: It was noticed that the use of medication during pregnancy through the practice of self-medication with Ibuprofen 9 (27%), Dipyrone 6 (18%), Bromopride 2 (6%), Paracetamol 13 (40%), Dimenhydrinate 3 (9 %), being 31 (94%) in the form of tablets was reported by 27 (33.75%) pregnant women, and 3 (11.1%) who had complaints of use such as headache, emesis and nausea and the indication was reported by 2 (6%) pregnant by the mother and the others on their own. Conclusion: After analyzing several scientific articles, what is very clear is that the use of non-steroidal anti-inflammatory drugs in early pregnancy has not shown to be a risk factor, however, after the first trimester it can be fatal, both for the occurrence of congenital structural malformations in the fetus, as for kidney problems. When it comes to the mother, it is clear that NSAIDs can prolong her delivery time, cause hemorrhages and weaken her eggs for future reproduction.
References
Albuquerque, V. M. T. & Tavares, C. A. (2011). Avaliação de indicadores de medicamentos: importância para a qualidade na prescrição médica. R. Bras. Farm. Hosp. Serv. Saúde São Paulo, 2(3), 31-35.
Antonucci, R., Zaffanello, M., Puxeddu, E., Porcella, A., Cuzzolin, L., Pilloni, M. D. & Fanos, V. (2012). Use of Non-steroidal Anti-inflammatory Drugs in Pregnancy: Impact on the Fetus and Newborn. Curr Drug Metab, 13(4), 474–90. DOI: 10.2174 / 138920012800166607
Bérard, A., Zhao, J-P. & Sheehy, O. (2017). Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec pregnancy cohort. BMJ Open, 7(1), 1-13.
Bloor, M. & Paech, M. (2013). Nonsteroidal anti-inflammatory drugs during pregnancy and the initiation of lactation. Anesth Analg. 116(5), 1063-1075.
Brasil. Associação Brasileira de Psiquiatria. (2018). Transtorno de Personalidade. https://www.abp.org.br/post/abptv-transtornos-de-personalidade
Brasil. Agência Nacional de Vigilância Sanitária (Anvisa). (2011). Resolução RDC nº 138, de 29 de maio de 2003. Dispõe sobre o enquadramento na categoria de venda de medicamentos. Diário Oficial da União, Poder Executivo, Brasília, DF.
Carvalho, V. C. P. & Araújo, T. V. B. (2013). Adequação da assistência pré-natal em gestantes atendidas em dois hospitais de referência para gravidez de alto risco do Sistema Único de Saúde, na cidade de Recife, Estado de Pernambuco. Rev. Bras. Saúde Matern.Infant, 7(3), 309-317.
FDA. Food and Drug Administration. (2019). Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling [Internet]. https://s3.amazonaws. com/public-inspection.federalregister.gov/2014-28241.pd
Gunatilake, R., & Patil, S. (2021). Uso de medicamentos durante a gravidez - Problemas de saúde feminina. Manual MSD Versão Saúde para a Família. https://www.msdmanuals.com/pt-br/casa/problemas-de-sa%C3%BAde-feminina/uso-de-medicamentos-drogas-durante-a-gesta%C3%A7%C3%A3o
Hurtado-Gonzales, P., Anderson, R. A., Macdonald, J., Driesche, S. V. D., Kilcoyne, K., Jorgenses, A., Mckinnel, C., Macpherson, S., Sharpe, R. & Mitchell, R. (2018). Effects of exposure to acetaminophen and ibuprofen of fetal germ cell development in both sexes in rodent and human using multiple experimental systems. Environ Health Perspect, 16(126), 1 - 17.
ISMP. Instituto para Práticas Seguras no Uso de Medicamentos. (2020). Desafio global de segurança do paciente: medicação sem danos [Internet]. Boletim ISMP Brasil. 7(1), 1-8.
Kallén, B. & Reis, M. (2015). Useof tramadol in early pregnancy and congenital malformation risk. Reproductive Toxicology, 58, 246-251.
Leverrier-Penna, S., Mitchell, R. T., Becker, E., Lecante, L., Maamar, M.B., Homer, N., Lavoué, V., Kristense, D. M., Dejucq-rainsford, N. & Jécou, B. (2018). Ibuprofen is deleterious for the development of first trimester human fetal ovary ex vivo. Human Reproduction, 33(3), 482-493.
Li, D. K., Liu, L. & Odouli, R. (2003). Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ, 327(7411), 368-372.
Lind, J. N., Interrante, J. D., Ailes, E. C., Gilboa, S. M., Khan, S., Frey, M. T., Dawson, A. L., Honein, M. A., Dowling, N. F., Razzaghi, H., Creanga, A. A. & Broussard, C. S. (2017). Maternal use of opioids during pregnancy and congenital malformations: a systematic review. Pediatrics. 139(6), 1-35.
Lunardi-Maia, T., Schuelter-TrevisoL, F. & Galato, D. (2014). Uso de medicamentos no primeiro trimestre de gravidez: avaliação da segurança dos medicamentos e uso de ácido fólico e sulfato ferroso. Rev Bras Ginecol Obstet, 36(12), 541-547.
Milléo, A. (2018). Ibuprofeno usado na gravidez prejudica a fertilidade das futuras gerações, aponta estudo. https://www.gazetadopovo.com.br/viver-bem/saude-e-bem-estar/anti-inflamatorio-na-gestacao-pode-prejudicar-fertilidade
Nakhai-Pour, H. R. & Berard, A. (2011). Major malformations after first-trimester exposure to aspirin and NSAIDs. Expert. Rev. Clin. Pharmacol., 1(5), 605-616.
Nascimento, A. M., Gonçalves, R. E. L. M., Medeiros, R. M. K. & Lisboa, H. C. F. (2016). Avaliação do uso de medicamentos por gestantes em Unidades Básicas de Saúde de Rondonópolis, Mato Grosso. Revista Eletrônica Gestão & Saúde, 07(01), 96-113.
Ofori, B., Oraichi, D., Blais, L., Rey, E. & Bérard, A. (2006). Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study. Birth Defects Res. B. Dev. Reprod. Toxicol., 77(4), 268-279.
Pinheiro, R. M. & Wannmacher, L. (2014). Uso racional de anti-inflamatórios não J. M. Silva, et al. ISSN 1983-6708 Revista Científica do ITPAC, 7(4), Pub.5, esteroides. In: Ministério Da Saúde. Uso Racional de Medicamentos Temas relacionados. Brasília: Editora MS, 2012. Cap. 5, p. 41-50
Quintanilha, D. O. (2020). Agência Americana orienta evitar anti-inflamatórios na gravidez. https://pebmed.com.br/agencia-americana-orienta-evitar-anti-inflamatorios-na-gravidez
Romani, F., Tropea, A., Scarinci, E., Federico, A., Dello Russo, C., Lisi, L., Catino, S., Lanzone, A., & Apa, R. (2014). Endocrine disrupters and human reproductive failure: the in vitro effect of phthalates on human luteal cells. Fertil Steril, 102(3), 831-837.
Sanamed. (2019). Anti-inflamatórios Não Esteroides (AINES): o que são e como funcionam. Https://www.sanarmed.com/anti-inflamatorios-nao-esteroides-aines.
Santos, S., Alves, H. & Barros, K. (2017). Estudo de indicadores de prescrição em gestantes de alto risco de um serviço de referência. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 8(4)25-30.
Seabra, C. I. R. (2015). Farmacocinética do Ibuprofeno. Tese de Doutorado.
Schaefer, C., Peters, P. W. & Miller, R. K. (2014). Drugs during pregnancy and lactation: treatment options and risk assessment. Academic Press.
Schmitt Júnior, A.A. Lindner, S. & De Santa Helena, E.T. (2013). Avaliação da adesão terapêutica em idosos atendidos na atenção primária. Rev Ass Med Bras, 59(6), 614-621.
Silva, J. A. C. da, Gomes, A. L., Oliveira, J. P. S. de, Sassaki, Y. de A., Maia, B. T. B. & Abreu, B. M. de. (2013). Prevalência de automedicação e os fatores associados entre os usuários de um Centro de Saúde Universitário. Rev Bras Clin Med, 11(1), 27-30.
Varalda, D. B. & Motta, A. A. (2011). Reações adversas aos antiinflamatórios não esteroidais. Rev. bras. alergia imunopatol, 32(1), 27-34.
Wilmer, E., Chai, S. & Kroumpouzos, G. (2016). Drug safety: pregnancy rating classifications and controversies. Clin Dermatol, 34(3), 401-409.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Nelma Menezes da Silva; Omero Martins Rodrigues Junior
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
